Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
about
Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumoniaLiver transplantation and the management of progressive familial intrahepatic cholestasis in childrenGood and bad lipids in the lungPhospholipase D2 mediates signaling by ATPase class I type 8B membrane 1P4 ATPases: flippases in health and diseasePhospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4Strain background modifies phenotypes in the ATP8B1-deficient mouse.Progressive familial intrahepatic cholestasis.Clinical application of transcriptional activators of bile salt transporters.Two Cases of Progressive Familial Intrahepatic Cholestasis Type 2 Presenting with Severe Coagulopathy without Jaundice.Bile formation and secretion.Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1Hepatobiliary quiz-10 (2014)Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia.Mutational analysis of ATP8B1 in patients with chronic pancreatitis.Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian familyThe Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.Structural and functional hepatocyte polarity and liver disease.Hepatobiliary transport in health and diseaseMorphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studiesBaseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension.A perspective on efflux transport proteins in the liverClinical utility gene card for: progressive familial intrahepatic cholestasis type 1.Clinical utility gene card for: progressive familial intrahepatic cholestasis type 2.An update on genetic analysis of cholestatic liver diseases: digging deeper.Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.Multiple Looser zones of osteomalacia in Byler disease with associated vitamin D deficiency, phosphaturia, and elevated FGF23.Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: Clinical Spectrum and Outcome.Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.Exon-skipping and mRNA decay in human liver tissue: molecular consequences of pathogenic bile salt export pump mutations.Mutation detection in cholestatic patients using microarray resequencing of ATP8B1 and ABCB11.Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.Loss-of-Function Mutations in UNC45A Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.Assessment of ATP8B1 Deficiency in Pediatric Patients With Cholestasis Using Peripheral Blood Monocyte-Derived Macrophages.Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.Novel splice-site mutation in ATP8B1 results in atypical progressive familial intrahepatic cholestasis type 1.Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.
P2860
Q23918727-65D07203-A842-4059-BACA-1359E7EF7654Q26745970-41374127-C700-4D7C-83D1-DCF65E3B3C34Q28384792-60E01CD2-58E9-402C-B12E-7DFB888887FEQ28395197-22D88282-AB0B-49B0-832A-A1CA21605E7EQ28397755-36E603EB-807E-4FE9-9838-90B36C1A0E74Q29248074-3AD16827-8B4D-4175-91B4-356B73CB9CDAQ33529062-5EB3821E-E07E-4027-9C37-A78B91EF8B18Q33595403-B5DF77AD-FE8E-426D-B493-755A05DD0CE0Q33709930-BDB2D264-13FB-4325-8BDA-10BEDE69824FQ33766117-E926BF2F-147C-41E3-81B5-3C42D483AC72Q33881922-ED65ADD7-523D-435F-8EDA-C136E20802C6Q33929416-7189F62D-45BF-4D30-9F2E-829D75AAC12AQ34302666-5992DD3D-458B-4B77-9A18-15AF53D708A8Q34569736-8D70104B-9116-463F-9FDF-525C7FD8CE6EQ35049102-99F2A327-BC83-46D6-8620-340FBA39252EQ35124972-67E4B894-77E0-4CA9-B178-9A7BE06AA9A7Q35981086-9A470D4E-1923-450F-B0CE-4DBE36AB94CAQ36090717-8DF94A10-52BF-491F-9E26-54F45CE62868Q36126750-ADE5C071-484C-44F9-B2EA-F1B3182D4311Q36154600-CEA2D210-C72E-43FA-BEDB-95EBDB48339BQ36407076-577F8779-BE77-4343-8DF0-00DD4C3C5331Q37050337-048244E4-7ED1-4933-A1FC-6E6FE0FA851EQ37636746-40FF7719-15FC-49E5-AE12-DC7CFB0D8829Q37636748-2EDCEBB0-5BBE-46B6-9B24-BDC0AFF79CDDQ37892287-3ED44CF2-8F9A-4EE4-99A9-05DFD6318FCCQ38262461-EB96C08B-0055-4C88-AD1B-F4572B5F0BA3Q38521077-A7B4FFD6-A2A0-4DF9-A3A0-96A48802BC42Q38634838-2D9F59D1-A5BD-4898-B802-67F3EC73712FQ38982098-7678E30E-11B8-455F-B965-8C3B6DFFB4B8Q39028290-D3621068-1B44-45F0-A789-30CBE24BD6E6Q39482657-4CBE5C06-F5F1-45DF-83F1-DAEA1FDF4130Q40625703-15DD2F46-9920-48D2-9842-3ED272A7858FQ41900678-4C2F6DAC-AC68-470C-A405-54E7F9221CECQ44511582-B3CB5EC2-87B9-4D74-AA0B-2DAD0FD83962Q50076522-F850BE1A-FEE0-4F96-BDDB-7D86C15A68F7Q50148637-AB887A93-DF56-4CDA-950B-BE9C1B53E4C0Q52652409-A449DED2-42AC-413D-B806-12B7F677A3C1Q54289327-BB3A8381-45DB-422D-99AD-FFE72BC767E4Q54957846-99A40146-545E-44ED-9109-C6695579298DQ55344969-31004BF5-626B-45B5-9339-FC07543DBC18
P2860
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@ast
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@en
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@nl
type
label
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@ast
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@en
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@nl
prefLabel
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@ast
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@en
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@nl
P2093
P2860
P1476
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
@en
P2093
A S Knisely
Albertien M van Eerde
Antal Nemeth
Anthony Antoniou
Benjamin Shneider
Billy Bourke
Bjorn Fischler
Catherine Wanty
Etienne Sokal
Florence Lacaille
P2860
P304
P356
10.1016/J.JHEP.2010.01.034
P577
2010-04-13T00:00:00Z